Skip to content

Welcome to Discover Pharma! Today is : November 11, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Research & Development

  • Biotech & Pharma Business,Drug Discovery & Development,Research & Development

    BioInnovation Institute expands into UK with London cardiometabolic innovation hub

    BioInnovation Institute has opened its first international base in London [...]

    June 29, 2026
  • Advanced Therapies,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development

    Chiesi and Arbor win EU orphan status for PH1 gene editing therapy

    The European Commission has granted orphan drug designation to Chiesi [...]

    June 28, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    China IgA nephropathy approval highlights rising dual-target biologic competition

    China’s approval of a first dual BAFF/APRIL therapy in IgA [...]

    June 25, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Racura treats first patient in Harness-1 lung cancer trial

    Racura Oncology has treated the first patient in its Harness-1 [...]

    June 25, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Research & Development,Therapeutic Areas

    EMBARC announces intention to collaborate with Insmed on landmark interventional study in bronchiectasis

    EMBARC has announced its intention to collaborate with Insmed on [...]

    June 28, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing,Research & Development

    Evogene advances ChemPass AI milestone in Google Cloud collaboration for autonomous small molecule discovery

    Evogene reports a major Google Cloud collaboration milestone advancing agentic [...]

    June 25, 2026
  • Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Al-S Pharma presents Phase 2 AP-101 data supporting misfolded SOD1 target in ALS at ENCALS 2026

    Al-S Pharma reports Phase 2 AP-101 data in ALS showing [...]

    June 25, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Thalia Therapeutics acquires Sanmirna and raises £2.75M to advance AML RNA therapy

    Thalia Therapeutics has agreed a Sanmirna acquisition and £2.75m fundraise [...]

    June 25, 2026
  • Drug Discovery & Development,Research & Development

    FairJourney Bio expands antibody discovery offering through AbTherx partnership

    FairJourney Bio has partnered with AbTherx to bring transgenic mouse-based [...]

    June 25, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development

    Absci reports positive Phase 1 data for hair loss antibody ABS-201

    Absci has reported positive interim Phase 1 data for ABS-201, [...]

    June 25, 2026
Previous2223

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Amyl Therapeutics raises €8.25M to advance pan-amyloid neurodegenerative disease platform
    Categories: Central Nervous System, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • CluePoints brings AI-powered clinical data review to DPHARM 2026
    Categories: Clinical & Regulatory, Digital & Data, Research & Development
  • NVision deploys quantum-enhanced MRI platform at Hokkaido University
    Categories: Digital & Data, Drug Discovery & Development, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top